| Selective inhibition of protein kinase C isozymes by the indolocarbazole Gö 6976 G Martiny-Baron, MG Kazanietz, H Mischak, PM Blumberg, G Kochs, ... Journal of Biological Chemistry 268 (13), 9194-9197, 1993 | 1908 | 1993 |
| Protein kinase C and other diacylglycerol effectors in cancer EM Griner, MG Kazanietz Nature Reviews Cancer 7 (4), 281-294, 2007 | 1196 | 2007 |
| Crystal structure of the Cys2 activator-binding domain of protein kinase Cδ in complex with phorbol ester G Zhang, MG Kazanietz, PM Blumberg, JH Hurley Cell 81 (6), 917-924, 1995 | 859 | 1995 |
| New insights into the regulation of protein kinase C and novel phorbol ester receptors D Ron, MG Kazanietz The FASEB Journal 13 (13), 1658-1676, 1999 | 790 | 1999 |
| Overexpression of protein kinase C-delta and-epsilon in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity. H Mischak, JA Goodnight, W Kolch, G Martiny-Baron, C Schaechtle, ... Journal of Biological Chemistry 268 (9), 6090-6096, 1993 | 701 | 1993 |
| Ca (2+)-dependent and Ca (2+)-independent isozymes of protein kinase C mediate exocytosis in antigen-stimulated rat basophilic RBL-2H3 cells. Reconstitution of secretory … K Ozawa, Z Szallasi, MG Kazanietz, PM Blumberg, H Mischak, ... Journal of Biological Chemistry 268 (3), 1749-1756, 1993 | 479 | 1993 |
| Characterization of ligand and substrate specificity for the calcium-dependent and calcium-independent protein kinase C isozymes. MG Kazanietz, LB Areces, A Bahador, H Mischak, J Goodnight, ... Molecular pharmacology 44 (2), 298-307, 1993 | 394 | 1993 |
| C1 domains exposed: from diacylglycerol binding to protein–protein interactions F Colón-González, MG Kazanietz Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2006 | 372 | 2006 |
| Protein kinase C and cancer: what we know and what we do not R Garg, LG Benedetti, MB Abera, H Wang, M Abba, MG Kazanietz Oncogene 33 (45), 5225-5237, 2014 | 334 | 2014 |
| Protein kinase C promotes apoptosis in LNCaP prostate cancer cells through activation of p38 MAPK and inhibition of the Akt survival pathway Y Tanaka, MV Gavrielides, Y Mitsuuchi, T Fujii, MG Kazanietz Journal of Biological Chemistry 278 (36), 33753-33762, 2003 | 326 | 2003 |
| Arachidonic acid in platelet microparticles up-regulates cyclooxygenase-2-dependent prostaglandin formation via a protein kinase C/mitogen-activated protein kinase-dependent … OP Barry, MG Kazanietz, D Pratico, GA FitzGerald Journal of Biological Chemistry 274 (11), 7545-7556, 1999 | 315 | 1999 |
| Phorbol ester-induced myeloid differentiation is mediated by protein kinase C-alpha and-delta and not by protein kinase C-beta II,-epsilon,-zeta, and-eta. H Mischak, JH Pierce, J Goodnight, MG Kazanietz, PM Blumberg, ... Journal of Biological Chemistry 268 (27), 20110-20115, 1993 | 312 | 1993 |
| Divergence and complexities in DAG signaling: looking beyond PKC CF Yang, MG Kazanietz Trends in pharmacological sciences 24 (11), 602-608, 2003 | 303 | 2003 |
| Novel “nonkinase” phorbol ester receptors: the C1 domain connection MG Kazanietz Molecular pharmacology 61 (4), 759-767, 2002 | 286 | 2002 |
| CXCL13 and its receptor CXCR5 in cancer: inflammation, immune response, and beyond MG Kazanietz, M Durando, M Cooke Frontiers in endocrinology 10, 471, 2019 | 276 | 2019 |
| Hedgehog proteins activate pro-angiogenic responses in endothelial cells through non-canonical signaling pathways P Chinchilla, L Xiao, MG Kazanietz, NA Riobo Cell cycle 9 (3), 570-579, 2010 | 261 | 2010 |
| Involvement of protein kinase C δ (PKCδ) in phorbol ester-induced apoptosis in LNCaP prostate cancer cells: lack of proteolytic cleavage of PKCδ T Fujii, ML Garcı́a-Bermejo, JL Bernabó, J Caamaño, M Ohba, T Kuroki, ... Journal of Biological Chemistry 275 (11), 7574-7582, 2000 | 252 | 2000 |
| Eyes wide shut: protein kinase C isozymes are not the only receptors for the phorbol ester tumor promoters MG Kazanietz Molecular Carcinogenesis: Published in cooperation with the University of …, 2000 | 244 | 2000 |
| Identification of the Rac-GEF P-Rex1 as an essential mediator of ErbB signaling in breast cancer MS Sosa, C Lopez-Haber, C Yang, HB Wang, MA Lemmon, JM Busillo, ... Molecular cell 40 (6), 877-892, 2010 | 241 | 2010 |
| Rac signaling in breast cancer: a tale of GEFs and GAPs E Wertheimer, A Gutierrez-Uzquiza, C Rosemblit, C Lopez-Haber, ... Cellular signalling 24 (2), 353-362, 2012 | 232 | 2012 |
